During concurrent use , patients should contact their healthcare provider if they experience: Symptoms of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat) Severe, persistent abdominal pain (often radiating to the back) with or without vomitingthis could indicate pancreatitis, a serious adverse effect associated with GLP-1 receptor agonists requiring urgent medical evaluation Unexplained fatigue, jaundice, or abdominal pain (potential liver concerns) Worsening gastrointestinal symptoms beyond typical semaglutide side effects New or unusual symptoms that may represent an adverse reaction Patients taking oral medications with a narrow therapeutic index should discuss timing and monitoring with their healthcare provider, as semaglutide's effect on gastric emptying may affect absorption
Rapid weight loss , a common effect of GLP-1 agonists, is a well-established risk factor for gallstone formation
Setting Realistic Expectations Counsel patients that plateaus are normal and that weight maintenance represents therapeutic success, not failure
Nausea usually lessens as you continue to take semaglutide
It mimics the effects of GLP-1, a hormone that stimulates insulin secretion in response to meals, thereby reducing blood sugar levels